Development
Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.56% | 523.65% | 18.72% | 4.10% | 57.26% |
| Total Receivables | -45.59% | 47.74% | -27.77% | -17.46% | 18.40% |
| Inventory | 15.22% | -7.70% | 14.63% | -48.30% | -4.77% |
| Prepaid Expenses | 332.90% | -58.60% | 26.24% | -51.75% | 4.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1,340.00% | -- | -- | -- | -- |
| Total Current Assets | 8.65% | 41.95% | -6.12% | -33.52% | 4.48% |
|
|
|||||
| Total Current Assets | 8.65% | 41.95% | -6.12% | -33.52% | 4.48% |
| Net Property, Plant & Equipment | -10.16% | -8.00% | -7.90% | -13.76% | -8.47% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -5.16% | 1.49% | -7.57% | -18.30% | -5.79% |
|
|
|||||
| Total Accounts Payable | 6.21% | 9.29% | 9.06% | 30.87% | 9.33% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -9.89% | -27.25% | -18.09% | 13.43% | 13.64% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -38.25% | 6.72% | -15.47% | 1.53% | -1.46% |
| Total Finance Division Other Current Liabilities | -- | -- | 3,803.06% | -55.45% | -7.95% |
| Total Other Current Liabilities | -- | -- | 3,803.06% | -55.45% | -7.95% |
| Total Current Liabilities | -1.41% | -9.91% | 9.00% | 21.45% | 9.64% |
|
|
|||||
| Total Current Liabilities | -1.41% | -9.91% | 9.00% | 21.45% | 9.64% |
| Long-Term Debt | 47.76% | 595.37% | 3.86% | -5.50% | -3.39% |
| Short-term Debt | -9.89% | -27.25% | -18.09% | 13.43% | 13.64% |
| Capital Leases | -- | -- | -- | -74.91% | -44.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.72% | 12.19% | 8.16% | 17.51% | 6.11% |
|
|
|||||
| Common Stock & APIC | 0.30% | 9.80% | -8.40% | -0.22% | -2.94% |
| Retained Earnings | -2.36% | -2.44% | -1.76% | -3.34% | 1.69% |
| Treasury Stock & Other | 3.37% | -50.04% | 110.55% | -1.68% | -3.39% |
| Total Common Equity | -17.84% | -19.04% | -21.39% | -86.18% | -40.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.84% | -19.04% | -21.39% | -86.18% | -40.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.84% | -19.04% | -21.39% | -86.18% | -40.04% |
|
|
|||||